EVH vs. TNET, FTDR, STNE, LIF, CNXC, CARG, PAGS, FA, ALIT, and QBTS
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include TriNet Group (TNET), Frontdoor (FTDR), StoneCo (STNE), Life360 (LIF), Concentrix (CNXC), CarGurus (CARG), PagSeguro Digital (PAGS), First Advantage (FA), Alight (ALIT), and D-Wave Quantum (QBTS). These companies are all part of the "business services" industry.
Evolent Health vs.
Evolent Health (NYSE:EVH) and TriNet Group (NYSE:TNET) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, community ranking, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.
Evolent Health received 221 more outperform votes than TriNet Group when rated by MarketBeat users. Likewise, 74.90% of users gave Evolent Health an outperform vote while only 66.42% of users gave TriNet Group an outperform vote.
TriNet Group has a net margin of 3.46% compared to Evolent Health's net margin of -2.41%. TriNet Group's return on equity of 200.82% beat Evolent Health's return on equity.
In the previous week, TriNet Group had 1 more articles in the media than Evolent Health. MarketBeat recorded 8 mentions for TriNet Group and 7 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.56 beat TriNet Group's score of 1.29 indicating that Evolent Health is being referred to more favorably in the media.
Evolent Health has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, TriNet Group has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500.
96.8% of TriNet Group shares are held by institutional investors. 1.4% of Evolent Health shares are held by company insiders. Comparatively, 38.1% of TriNet Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
TriNet Group has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks.
Evolent Health presently has a consensus target price of $17.79, suggesting a potential upside of 121.63%. TriNet Group has a consensus target price of $96.67, suggesting a potential upside of 16.19%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts clearly believe Evolent Health is more favorable than TriNet Group.
Summary
TriNet Group beats Evolent Health on 11 of the 19 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
This page (NYSE:EVH) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy EVH Stock Free EVH Stock Alerts